期刊
CURRENT OPINION IN IMMUNOLOGY
卷 43, 期 -, 页码 46-53出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2016.09.002
关键词
-
类别
资金
- National Institutes of Health
- National Multiple Sclerosis Society
- International Progressive MS Alliance
- American Cancer Society
- Mallinckrodt Pharmaceuticals
- Deutsche Forschungsgemeinschaft (DFG)
Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating disorder of the central nervous system (CNS), which causes severe disability and requires extensive medical attention and treatment. While the infiltration of pathogenic immune cells into the CNS leads to the formation of inflammatory lesions in its initial relapsing-remitting stage, late stages of MS are characterized by progressive neuronal loss and demyelination even without continued interaction with the peripheral immune compartment. Several genetic and environmental factors modulate and influence these processes on multiple levels. Genetic variants confer a predisposition for the development of MS, but are not accessible to therapeutic intervention as of today. However, migration studies suggest that environmental factors influence disease development, activity and progression. This article reviews mechanisms of disease pathogenesis in MS and their modulation by environmental factors such as geographical localization, the gut microbiome and the diet.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据